Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy Publisher

Fakhari A¹ ; Jalilian AR² ; Yousefnia H² ; Joharidaha F² ; Mazidi M² ; Khalaj A¹

Source: Journal of Radioanalytical and Nuclear Chemistry Published:2015

Abstract

In this work 166Ho labeled (3-amino-1-hydroxypropane-1,1-di-yl)-bis-(phosphonate) (166Ho-PMD) complex was prepared successfully at optimized conditions with acceptable radiochemical purity, stability and significant hydroxyapatite absorption. The biodistribution of 166Ho-PMD up to 48 h demonstrated significant bone uptake ratios at all time intervals but not superior to 166Ho-EDTMP. © 2014, Akademiai Kiado, Budapest, Hungary.

Related Docs

View other Related Docs

1. Radiolabeling and Evaluation of Two 177Lu-Labeled Bis-Phosphonates, Iranian Journal of Nuclear Medicine (2015)

2. Production, Quality Control, Biodistribution Assessment and Preliminary Dose Evaluation of 166Ho-Alendronate As a Bone Marrow Ablative Agent, Radiochimica Acta (2015)

3. An Impressive Approach in Nuclear Medicine: Theranostics, PET Clinics (2021)

Experts (# of related papers)

View all Related Experts

Mahmoud Azami (3)

Davood Beiki (3)

Other Related Docs

4. Development of 153Sm/177Lu-Edtmp As a Possible Therapeutic Complex, Iranian Journal of Nuclear Medicine (2017)

5. Efficacy of the Biomaterials 3 Wt%-Nanostrontium-Hydroxyapatite-Enhanced Calcium Phosphate Cement (Nanosr-Cpc) and Nanosr-Cpc-Incorporated Simvastatin-Loaded Poly(Lactic-Co-Glycolic-Acid) Microspheres in Osteogenesis Improvement: An Explorative Multi-Phase Experimental in Vitro/Vivo Study, Materials Science and Engineering C (2016)

6. A Comparative Study of 3D-Printed Scaffolds Fabricated From Different Hydroxyapatite Sources for Bone Tissue Engineering Applications, Advanced Composite Materials (2024)

7. Topical Erythropoietin As a Novel Preventive and Therapeutic Agent in Bisphosphonate-Related Osteonecrosis of the Jaw, Dental Hypotheses (2016)

8. Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain, Journal of Clinical Medicine (2020)

9. A Meticulous Biocompatibility and Toxicological Assessment of a Self-Assembling Peptide Nanofiber-Nanoceramic Biomimetic Nanocomposite, Per Iso 10993 Guidelines, Nanotoxicology (2025)

10. Investigation of Magnesium Incorporation Within Gelatin/Calcium Phosphate Nanocomposite Scaffold for Bone Tissue Engineering, International Journal of Applied Ceramic Technology (2015)

11. Evaluation of 153Sm/177Lu-Edtmp Mixture in Wild-Type Rodents As a Novel Combined Palliative Treatment of Bone Pain Agent, Journal of Radioanalytical and Nuclear Chemistry (2015)

12. Incorporation of Calcium Phosphate Cement Into Decellularized Extracellular Matrix Enhances Its Bone Regenerative Properties, Colloids and Surfaces B: Biointerfaces (2024)

13. Evaluation of Mechanical and Biocompatibility Properties of Hydroxyapatite/Manganese Dioxide Nanocomposite Scaffolds for Bone Tissue Engineering Application, International Journal of Applied Ceramic Technology (2020)

14. Novel Layered Double Hydroxides-Hydroxyapatite/Gelatin Bone Tissue Engineering Scaffolds: Fabrication, Characterization, and in Vivo Study, Materials Science and Engineering C (2017)

15. Comparison of Bone Mineral Density of Osteoporotic and Osteopenia Menopausal Women Treated With Oral Bisphosphonates Before Stopping the Treatment and 1 Year After Drug Holiday Period, Clinical Rheumatology (2024)

16. Optimized Production and Quality Control of 68Ga-Edtmp for Small Clinical Trials, Annals of Nuclear Medicine (2015)

17. Liquid Calibration Phantoms in Ultra-Low-Dose Qct for the Assessment of Bone Mineral Density, Journal of Clinical Densitometry (2020)

18. Applying Extrusion-Based 3D Printing Technique Accelerates Fabricating Complex Biphasic Calcium Phosphate-Based Scaffolds for Bone Tissue Regeneration, Journal of Advanced Research (2022)

19. Tricalcium Phosphate Nanostructures Loaded With Bisphosphonate As Potential Anticancer Agents, Journal of Ceramic Science and Technology (2017)

20. Synergistic Effects of Carbohydrate Polymers on the Performance of Hybrid Injectable Bone Pastes, European Polymer Journal (2019)

Style	Citing Format
MLA	Fakhari A, et al.. "Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy." Journal of Radioanalytical and Nuclear Chemistry, vol. 303, no. 1, 2015, pp. 743-750.
APA	Fakhari A, Jalilian AR, Yousefnia H, Joharidaha F, Mazidi M, Khalaj A (2015). Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy. Journal of Radioanalytical and Nuclear Chemistry, 303(1), 743-750.
Chicago	Fakhari A, Jalilian AR, Yousefnia H, Joharidaha F, Mazidi M, Khalaj A. "Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy." Journal of Radioanalytical and Nuclear Chemistry 303, no. 1 (2015): 743-750.
Harvard	Fakhari A et al. (2015) 'Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy', Journal of Radioanalytical and Nuclear Chemistry, 303(1), pp. 743-750.
Vancouver	Fakhari A, Jalilian AR, Yousefnia H, Joharidaha F, Mazidi M, Khalaj A. Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy. Journal of Radioanalytical and Nuclear Chemistry. 2015;303(1):743-750.
BibTex	@article{ author = {Fakhari A and Jalilian AR and Yousefnia H and Joharidaha F and Mazidi M and Khalaj A}, title = {Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy}, journal = {Journal of Radioanalytical and Nuclear Chemistry}, volume = {303}, number = {1}, pages = {743-750}, year = {2015} }
RIS	TY - JOUR AU - Fakhari A AU - Jalilian AR AU - Yousefnia H AU - Joharidaha F AU - Mazidi M AU - Khalaj A TI - Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy JO - Journal of Radioanalytical and Nuclear Chemistry VL - 303 IS - 1 SP - 743 EP - 750 PY - 2015 ER -